clinical development

Technical, preclinical, and clinical developments of Fc-glycan-specific antibody–drug conjugates

RSC Med. Chem., 2024, Advance Article
DOI: 10.1039/D4MD00637B, Review Article
Open Access
  This article is licensed under a Creative Commons Attribution 3.0 Unported Licence.
Qiang Yang, Yunpeng Liu
Fc-glycan-specific ADC is a significant advance in site-specific ADCs for cancer therapy. Notably, JSKN003 and IBI343 have demonstrated promising results in phase 1 clinical trials and are advancing into phase 3 studies.
To cite this article before page numbers are assigned, use the DOI form of citation above.
The content of this RSS Feed (c) The Royal Society of Chemistry




clinical development

Antibiotics Currently in Global Clinical Development

As of December 2019, approximately 41 new antibiotics with the potential to treat serious bacterial infections were in clinical development, and four were approved since the previous update in June 2019. The success rate for clinical drug development is low; historical data show that, generally, only 1 in 5 infectious disease products that enter human testing (phase 1 clinical trials) will be...




clinical development

Statistical methods in biomarker and early clinical development [Electronic book] / Liang Fang, Cheng Su, editors.

Cham, Switzerland : Springer, [2019]




clinical development

STATISTICAL METHODS IN BIOMARKER AND EARLY CLINICAL DEVELOPMENT [Electronic book].

[S.l.] : SPRINGER, 2020.